Cost Effectiveness and Resource Allocation

Papers
(The TQCC of Cost Effectiveness and Resource Allocation is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-01-01 to 2024-01-01.)
ArticleCitations
Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review65
Establishing a reasonable price for an orphan drug43
Technical efficiency of provincial public healthcare in South Africa36
Cost-effectiveness and resource allocation (CERA) 18 years of evolution: maturity of adulthood and promise beyond tomorrow30
The effect of medical insurance on catastrophic health expenditure: evidence from China26
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds24
Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making22
Status and determinants of enrollment and dropout of health insurance in Nepal: an explorative study22
What makes inequality in the area of dental and oral health in developing countries? A scoping review19
Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran17
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US17
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis15
Is bed turnover rate a good metric for hospital scale efficiency? A measure of resource utilization rate for hospitals in Southeast Nigeria15
Determinants of catastrophic health expenditures in Iran: a systematic review and meta-analysis15
Health systems efficiency in Eastern Mediterranean Region: a data envelopment analysis15
How much the Iranian government spent on disasters in the last 100 years? A critical policy analysis14
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis13
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation13
Level and determinants of county health system technical efficiency in Kenya: two stage data envelopment analysis12
Household catastrophic health expenditure and its effective factors: a case of Iran12
Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package12
Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation11
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making11
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma11
Strategies for reducing out of pocket payments in the health system: a scoping review11
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review10
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis10
Some reflections on the use of inappropriate comparators in CEA10
Ranking of Iranian provinces based on healthcare infrastructures: before and after implementation of Health Transformation Plan10
Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review10
Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care9
Comparison of cost effectiveness between video-assisted thoracoscopic surgery (vats) and open lobectomy: a retrospective study9
Predicting positive organizational behavior based on structural and psychological empowerment among nurses9
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy9
Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong9
Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective9
Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone8
Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment8
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?8
Market access and value-based pricing of digital health applications in Germany8
Cost effectiveness of outpatient lumbar discectomy8
Assessing the efficiency of Iran health system in making progress towards universal health coverage: a comparative panel data analysis8
Modeling the Cost-effectiveness of Esophageal Cancer Screening in China7
Factors affecting the technical efficiency of rural primary health care centers in Hamadan, Iran: data envelopment analysis and Tobit regression7
The effect of different classification of hospitals on medical expenditure from perspective of classification of hospitals framework: evidence from China7
Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise7
Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective7
The use of evaluation methods for the overall assessment of health policy: potential and limitations6
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings6
Dynamic linkages among economic development, environmental pollution and human health in Chinese6
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong6
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan6
Hospital efficiency measurement in the west of Iran: data envelopment analysis and econometric approach6
Methodological challenges surrounding QALY estimation for paediatric economic evaluation6
Cost-effectiveness of facility-based, stand-alone and mobile-based voluntary counseling and testing for HIV in Addis Ababa, Ethiopia6
Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only6
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China6
Cost transferability problems in economic evaluation as a framework for an European health care and social costs database6
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey6
Comparison of the healthcare system of Chile and Brazil: strengths, inefficiencies, and expenditures5
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives5
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases5
Cost-effectiveness of a novel smartphone application to mobilize first responders after witnessed OHCA in Belgium5
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact5
Recommendations to improve insurance coverage for physiotherapy services in Iran: a multi criteria decision-making approach5
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong5
Exploring physicians and patients’ perspectives for current interventions on thyroid nodules using a MCDA method5
Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries5
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana5
What is the time cost of exercise? Cost of time spent on exercise in a primary health care intervention to increase physical activity5
The influence of medical insurance and social security cards on the floating population's settlement intention5
A comprehensive framework for considering additional unintended consequences in economic evaluation5
The pharmaceutical practice of mask distribution by pharmacists in Taiwan’s community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreak5
Budget impact analysis of lens material on the posterior capsule opacification (PCO) as a complication after the cataract surgery4
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China4
Total productivity change of Health Centers in Greece in 2016–2018: a Malmquist index data envelopment analysis application for the primary health system of Greece4
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method4
Impact of quality certification of multidisciplinary head and neck tumor centers4
Neural networks and hospital length of stay: an application to support healthcare management with national benchmarks and thresholds4
Cost-effectiveness analysis of nonoperative management versus open and laparoscopic surgery for uncomplicated acute appendicitis in Colombia4
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial4
The potential of real-time analytics to improve care for mechanically ventilated patients in the intensive care unit: an early economic evaluation4
A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt4
Changes in productivity in healthcare services in the Kingdom of Saudi Arabia4
Risk factors associated with postoperative complications after liver cancer resection surgery in western China4
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—20234
Examination on level of scale efficiency in public hospitals in Tanzania4
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china4
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan4
Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?4
The health care sector in the economies of the European Union: an overview using an input–output framework4
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation4
A systematic review of the budget impact analyses for antitumor drugs of lung cancer4
Association between changes in economic activity and catastrophic health expenditure: findings from the Korea Health Panel Survey, 2014–20164
0.020820140838623